Elevance Health, Inc. Financial Ratios — 4ANTM Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	11.24	11.28	10.25	10.49	10.83	10.26	14.89	13.63	15.95	14.08	17.78	16.3	15.85	14.83	13.29
Return on Assets (%)	5.17	4.78	4.2	4.24	4.15	3.9	5.67	5.28	6.45	5.57	6.69	5.89	5.66	5.3	4.75
Return on Capital (%)	8.91	8.36	7.44	7.44	7.47	7.18	10.45	9.15	10.86	9.8	12.07	10.97	10.86	10.04	9.21
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	6.52	6.27	5.41	5.91	5.85	5.37	4.4	5.5	5.74	5.12	5.77	4.85	4.5	4.47	3.37
Profit Margin (%)	4.36	4.32	3.51	3.48	3.23	2.91	4.27	4.07	4.61	3.75	4.44	3.76	3.49	3.38	2.84
Net Income to Common Margin (%)	4.36	4.32	3.51	3.48	3.23	2.91	4.27	4.07	4.61	3.75	4.44	3.76	3.49	3.38	2.84
Effective Tax Rate (%)	33.13	31.29	31.4	41.39	44.72	45.77	3.05	26.01	19.68	26.71	23.09	22.53	22.35	24.46	15.63
Dvd Payout Ratio (%)	13.52	13.85	17.01	18.78	25.65	27.69	18.35	20.69	17.02	20.87	17.98	20.89	23.27	25.29	27.01
Sustainable Growth Rate (%)	9.72	9.72	8.51	8.52	8.05	7.42	12.16	10.81	13.24	11.14	14.59	12.9	12.16	11.08	9.7

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	9,840	14,978	14,492	15,044	15,865	15,727	19,932	19,211	20,085	20,035	23,031	24,114	25,120	31,232	32,046
ST Debt	1,375	807	918	1,024	540	1,368	2,550	1,994	2,298	700	1,874	1,765	1,874	2,014	1,249
LT Debt	8,466	14,171	13,574	14,020	15,325	14,359	17,382	17,217	17,787	19,335	21,157	22,349	23,246	29,218	30,797
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	430	512	603	601	653	723	739	753	746	784	798	851	1,030	1,185	1,402
Common Equity/Total Assets	44.64	40.37	41.57	39.32	37.34	38.57	37.57	39.88	40.96	38.33	37	35.27	36.08	35.35	36.12
Long-Term Debt/Equity (%)	36.35	59.53	54.81	57.81	66.5	57.2	65.59	60.32	56.06	58.24	58.56	61.52	58.99	70.53	69.95
Long-Term Debt/Capital (%)	25.55	36.54	34.58	35.68	39.39	35.17	37.43	36.06	34.33	36.32	35.76	36.97	36.03	40.21	40.48
Long-Term Debt/Total Assets (%)	16.23	24.04	22.78	22.73	24.83	22.06	24.64	24.06	22.96	22.32	21.71	21.75	21.34	25	25.35
Total Debt/Equity (%)	42.25	62.93	58.52	62.03	68.84	62.66	75.21	67.31	63.3	60.35	63.75	66.37	63.75	75.39	72.79
Total Debt/Capital (%)	29.7	38.62	36.91	38.28	40.77	38.52	42.92	40.23	38.76	37.64	38.93	39.89	38.93	42.98	42.13
Total Debt/Total Assets (%)	18.86	25.41	24.33	24.39	25.7	24.16	28.26	26.84	25.93	23.13	23.63	23.47	23.06	26.72	26.38
Net Debt to Equity	32.8	52.53	52.13	53.16	59.67	46.42	61.59	53.53	47.74	43.06	50.24	46.04	47.19	55.39	51.23
Net Debt/Capital (%)	24.7	34.44	34.27	34.71	37.37	31.7	38.11	34.86	32.32	30.1	33.44	31.53	32.06	35.64	33.88
EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Current Ratio	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Quick Ratio	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
CFO/Avg Current Liab	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	44.64	40.37	41.57	39.32	37.34	38.57	37.57	39.88	40.96	38.33	37	35.27	36.08	35.35	36.12
Long-Term Debt/Equity (%)	36.35	59.53	54.81	57.81	66.5	57.2	65.59	60.32	56.06	58.24	58.56	61.52	58.99	70.53	69.95
Long-Term Debt/Capital (%)	25.55	36.54	34.58	35.68	39.39	35.17	37.43	36.06	34.33	36.32	35.76	36.97	36.03	40.21	40.48
Long-Term Debt/Total Assets (%)	16.23	24.04	22.78	22.73	24.83	22.06	24.64	24.06	22.96	22.32	21.71	21.75	21.34	25	25.35
Total Debt/Equity (%)	42.25	62.93	58.52	62.03	68.84	62.66	75.21	67.31	63.3	60.35	63.75	66.37	63.75	75.39	72.79
Total Debt/Capital (%)	29.7	38.62	36.91	38.28	40.77	38.52	42.92	40.23	38.76	37.64	38.93	39.89	38.93	42.98	42.13
Total Debt/Total Assets (%)	18.86	25.41	24.33	24.39	25.7	24.16	28.26	26.84	25.93	23.13	23.63	23.47	23.06	26.72	26.38
CFO/Total Liabilities	11.69	7.81	8.77	9	10.89	8.18	9.5	8.89	13.26	20.01	13.64	12.64	11.59	7.7	5.54
CFO/CapEx	6.5	5.04	4.72	4.71	6.6	5.6	5.29	3.17	5.63	10.47	7.69	7.29	6.22	4.62	3.84
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	18.84	17.35	18.55	16.8	16.79	16.22	14.95	14.25	17.73	23.68	25.3	24.54	22.87	22.22	22.02
Days Sales Outstanding	19.37	21.04	19.67	21.73	21.74	22.5	24.42	25.62	20.59	15.41	14.43	14.88	15.96	16.43	16.57
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	121,846	109,087	83,428	76,479
- Cash & Cash Equivalents	2,202	2,475	1,582	2,152	2,114	4,075	3,609	3,934	4,937	5,741	4,880	7,387	6,526	8,288	9,491
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	68	87	99	111	144
+ Total Debt	9,840	14,978	14,492	15,044	15,865	15,727	19,932	19,211	20,085	20,035	23,031	24,114	25,120	31,232	32,046
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	112,708	98,166	81,282	73,294
Total Capital	33,128	38,781	39,257	39,295	38,909	40,827	46,435	47,752	51,813	53,234	59,159	60,444	64,525	72,658	76,072
Total Debt/Capital (%)	29.7	38.62	36.91	38.28	40.77	38.52	42.92	40.23	38.76	37.64	38.93	39.89	38.93	42.98	42.13
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.21	0.26	0.38	0.44
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.72	0.57	0.46	0.37
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.44	11.08	12.13	13.39
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.26	12.98	14.92	16.82
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	124,325	111,113	85,416	77,822
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	115,187	100,192	83,270	74,637
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	473.64	421.19	357.32	332.06
TTM Sales	60,711	61,497	71,024	73,874	79,157	84,863	90,040	92,105	104,213	121,867	138,639	156,595	171,340	176,810	199,125
TTM EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Cash Flow to Firm	3,662	3,096	3,466	3,721	4,573	3,662	4,901	4,384	6,660	11,263	8,978	9,058	8,861	6,703	5,473
TTM Free Cash Flow to Firm	3,143	2,551	2,819	3,007	3,935	3,078	4,110	3,176	5,583	10,242	7,891	7,906	7,565	5,447	4,357

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	17.16	16.42	18.76	24.52
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	112,708	98,166	81,282	73,294
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	463.55	419.94	362.56	278.18
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.72	0.57	0.46	0.37
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	20.67	18.22	13.95	13.51
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	20.49	18.05	18.86	14.12
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.06	20.02	21.56	17.22
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.72	16.35	13.79	10.84
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.36	2.78	2.02	1.74
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.33	2.75	2.73	1.82
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.59	3.05	3.12	2.22
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.04	2.49	2	1.4
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	78.86	29.36	88.38	17.63
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	78.18	29.09	119.5	18.43
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	84.15	32.26	136.57	22.48
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	71.4	26.34	87.37	14.15
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.78	0.64	0.47	0.38
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.77	0.63	0.64	0.4
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.83	0.7	0.73	0.49
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.7	0.57	0.47	0.31
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.51	13.53	14.36	17.83
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.38	13.41	19.42	18.64
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.48	14.87	22.2	22.73
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.13	12.14	14.2	14.31
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	17.01	16.27	25.37	25.63
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.31	18.05	29	31.26
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.53	14.74	18.55	19.68
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.71	0.57	0.63	0.39
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.77	0.64	0.72	0.47
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.65	0.51	0.45	0.29
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	512.05	468.04	366.75	346.49
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	546.36	514.3	566.76	441.81
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	111,648	97,160	110,665	76,770
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	120,873	108,947	126,780	94,333
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	101,168	86,955	80,330	58,216

Shares Outstanding	339	305	293	268	261	264	256	257	253	245	242	238	233	227	221
Diluted Weighted Avg Shares	365	325	304	286	273	268	268	264	260	254	247	243	237	233	225
Basic Weighted Avg Shares	339	305	293	268	261	264	256	257	253	245	242	238	233	227	221
Revenue per Share	178.89	201.82	242.17	275.54	303.01	321.76	351.6	357.83	412.04	496.6	573.43	658.08	735.14	777.26	902.15
EBITDA per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	7.8	8.71	8.49	9.58	9.8	9.37	15.01	14.57	19.01	18.63	25.47	24.77	25.69	26.29	25.65
Basic EPS from Cont Ops	7.8	8.7	8.98	9.55	9.8	9.37	15.01	14.57	19.01	18.63	25.43	24.74	25.7	26.25	25.65
Diluted EPS, GAAP	7.25	8.18	8.2	8.99	9.38	9.21	14.35	14.19	18.47	17.98	24.95	24.28	25.22	25.68	25.21
Diluted EPS from Cont Ops	7.25	8.16	8.67	8.95	9.38	9.21	14.35	14.19	18.47	17.98	24.91	24.25	25.24	25.64	25.2
Dividend per Share	1.05	1.2	1.53	1.79	2.51	2.59	2.75	3.01	3.23	3.89	4.57	5.16	5.99	6.63	6.93
Cash Flow per Share	9.94	9.01	10.41	12.57	16.12	12.4	16.34	14.87	23.96	43.55	34.59	35.3	34.59	25.53	19.44
Free Cash Flow per Basic Share	8.41	7.22	8.2	9.9	13.68	10.18	13.25	10.18	19.71	39.39	30.1	30.45	29.03	20.01	14.38
Cash & Equivalents per Share	53.42	63.68	63.55	73.25	72.93	80.59	82.02	80.22	97.31	118.88	128.83	140.1	155.06	147.22	160.27
Book Value per Share	68.62	78.11	84.44	90.45	88.21	95.17	103.49	110.88	125.45	135.28	149.15	152.31	168.64	181.62	198.81
Tangible Book Value per Share	4.41	-5.75	-2.02	-2.94	-10.24	-1.61	-4.28	-3.77	10.1	8.57	5.03	6.49	15.94	4.15	19.65

Elevance Health, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)